Abiopharma

🔍 West Tony (Executive)

Company: Uber Technologies, Inc (UBER)

Report Date: 2026-08-16

Detailed Transactions and Holdings:

• Acquired 1,510 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 252,756.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,282 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 254,038.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,493 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 255,531.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,911 shares of Common Stock (Direct)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 258,442.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 749 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 257,693.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 636 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 257,057.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 741 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 256,316.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,444 shares of Common Stock at $75.95 per share (Direct)
  Date: 2026-08-16 | Code: F | equity_swap_involved: false | shares_owned_after: 254,872.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,510 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 64,951.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Sold 1,282 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 39,740.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4
• Sold 1,493 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 28,371.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Sold 2,911 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-16 | Code: M | equity_swap_involved: false | shares_owned_after: 20,372.00 | transaction_form_type: 4 | Footnotes: F1, F6, F6

Footnotes:

• F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
• F2: Shares withheld to satisfy tax liability upon vesting of RSUs on August 16, 2026.
• F3: The reporting person was granted 72,503 RSUs on March 2, 2026. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2026 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F4: The reporting person was granted 61,533 RSUs on March 3, 2025. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2025 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F5: The reporting person was granted 71,674 RSUs on March 1, 2024. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2024 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• F6: The reporting person was granted 139,697 RSUs on March 1, 2023. The vesting schedule is as follows: 1/48 of the total RSUs vested on April 16, 2023 and 1/48 of the total RSUs vest each month thereafter. Upon vesting, the RSUs become payable in cash or common stock on a one-for-one basis at the election of the Issuer.
• REMARKS: Chief Legal Officer and Corporate Secretary